AzTrials
AzTrials

Mechanically-ventilated PatientsInclinometre2NCT02184793

Impact of an Electronic Monitoring Device on Maintaining a Correct Elevation of Head of Bed for Mechanically-ventilated Patients in Intensive Care Unit

A study testing EMD (Inclinomax) in people with Mechanically-ventilated Patients, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Maintaining mechanically-ventilated patients in semi-recumbent position (defined by a head of bed inclination between 30° and 45°) would decrease the risk of pneumopathy occurrence in those patients. However, such a bed inclination frame is still difficult to maintain in day-to-day care. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mechanically-ventilated Patients
What is being tested?
EMD (Inclinomax)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
105 participants
Where
1 siteFrance
Study dates
Jun 2014to Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patient with invasive mechanical ventilation
  • expected mechanical ventilation duration for more than 48h after inclusion
  • signature of an informed consent by a relative
  • patient affiliated to a social security scheme (beneficiary or assignee)

Who cannot join

  • age<18 years old
  • mechanical ventilation with tracheotomy
  • contraindication to semirecumbent position (e.g., spinal cord injury, important sacral bedsore, counterpulsation balloon, femoral cannulation for extracorporeal circulation) or expected indication to another position within the following 48 h after inclusion (e.g., ventral decubitus for hypoxemia pulmonary pathology)
  • SAPS II score > 65 at the admission (moribund patients)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Bichat Claude Bernard

    Paris, 75018

Other trials in France

About this study

Maintaining mechanically-ventilated patients in semi-recumbent position (defined by a head of bed inclination between 30° and 45°) would decrease the risk of pneumopathy occurrence in those patients. However, such a bed inclination frame is still difficult to maintain in day-to-day care.

The aim of the study is to evaluate the impact of an electronic monitoring device on the proportion of time spent per day in semi-recumbent position, as defined by a head of bed inclination between 40° and 50°, in mechanically-ventilated patients.

Read the detailed description

Maintaining semi-recumbent position (defined by a head of bed inclination between 40° and 50°) is an international guidance to prevent ventilator-associated pneumopathy which is the main nosocomial infection in intensive care unit. However, maintaining such an inclination has been shown to be difficult in day-to-day care.

This could be improved by using an assistance device that would measure inclination of the head of bed in real time and trigger an alarm when the value order is not reached, hence allowing a quick readjustment if necessary.

The investigators want to evaluate en electronic monitoring device (EMD) that is removable and adjustable to all beds, which would allow a whole intensive care unit to be fully equipped at low cost.

Hypothesis : using an EMD could improve the proportion of time spent per day in semi-recumbent position (defined by a head of bed inclination between 40° and 50°) in mechanically-ventilated patients.

Primary objective : to evaluate the impact of an EMD with alarm on the proportion of time spent per day in semi-recumbent position, as defined by a head of bed inclination between 40° and 50°, in mechanically-ventilated patients.

Secondary objectives :

  • to evaluate the impact of the EMD on the head of bed inclination overall mean
  • to evaluate the impact of the EMD on the proportion of time spent per day with a head of bed inclination superior to 30°
  • to evaluate the impact of the EMD on the proportion of time spent per day with a head of bed inclination between 30° and 45°
  • to study factors associated to a head of bed inclination inferior to 30° for more than 12hrs per 24hrs
Being tested
EMD (Inclinomax)
Keywords
mechanical ventilation, semirecumbent position, electronic monitoring device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EMD (Inclinomax)Device

    Also called EMD (electronic monitoring device)

    EMD (electronic monitoring device) : recording the head of bed inclination degree with digital display and alarm on

Study groups in NCT02184793
Study groupRoleWhat they receive
EMD (Inclinomax) then usual careOtherEMD (electronic monitoring device) : recording the head of bed inclination degree with digital display and alarm on for 24h. Usual care : recording the head of bed inclination degree with masked digital display and alarm off for 24h.
Receives: Device: EMD (Inclinomax)
usual care then EMD (Inclinomax)OtherUsual care : recording the head of bed inclination degree with masked digital display and alarm off for 24h. EMD (electronic monitoring device) : recording the head of bed inclination degree with digital display and alarm on for 24h.
Receives: Device: EMD (Inclinomax)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. proportion of time spent per day in semirecumbent position as defined by a head of bed inclination between 40° and 50°

    head of bed inclination recording during 24h

    Measured: 24hrs

Secondary outcomes (3)
  1. head of bed inclination overall mean

    head of bed inclination recording during 24h

    Measured: 24hrs

  2. proportion of time spent per day with a head of bed inclination superior to 30°

    head of bed inclination recording during 24h

    Measured: 24hrs

  3. proportion of time spent per day with a head of bed inclination between 30° and 45°

    head of bed inclination recording during 24h

    Measured: 24hrs

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2014 (estimated)
  2. Study startJun 2014
  3. Primary completionApr 2017
  4. Study completionApr 2017

Why it stopped: not enough inclusion

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
105 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02184793
Sponsor's protocol ID
P080407
Acronym
Inclinometre2
Status last verified
May 2017
First submitted
25 Jun 2014
Last updated
15 Jun 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing EMD (Inclinomax) in people with Mechanically-ventilated Patients, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 15 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: not enough inclusion). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

proportion of time spent per day in semirecumbent position as defined by a head of bed inclination between 40° and 50° (time frame: 24hrs). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in